Fred Alger Management, LLC Acadia Pharmaceuticals Inc Transaction History
Fred Alger Management, LLC
- $16.5 Billion
- Q1 2025
A detailed history of Fred Alger Management, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Fred Alger Management, LLC holds 2,769,828 shares of ACAD stock, worth $62.5 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
2,769,828
Previous 2,714,929
2.02%
Holding current value
$62.5 Million
Previous $49.8 Million
7.65%
% of portfolio
0.28%
Previous 0.25%
Shares
31 transactions
Others Institutions Holding ACAD
# of Institutions
358Shares Held
163MCall Options Held
1.77MPut Options Held
307K-
Baker Bros. Advisors LP New York, NY42.9MShares$968 Million8.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$343 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$272 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.54MShares$193 Million2.32% of portfolio
-
State Street Corp Boston, MA6.99MShares$158 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.65B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...